ArticleHematological oncology2022

"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.

Léopoldine Lapierre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.